Literature DB >> 25040689

The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping.

Fiona E Braegger1, Lori Asarian, Kirsten Dahl, Thomas A Lutz, Christina N Boyle.   

Abstract

Amylin reduces meal size by activating noradrenergic neurons in the area postrema (AP). Neurons in the AP also mediate the eating-inhibitory effects of salmon calcitonin (sCT), a potent amylin agonist, but the phenotypes of the neurons mediating its effect are unknown. Here we investigated whether sCT activates similar neuronal populations to amylin, and if its anorectic properties also depend on AP function. Male rats underwent AP lesion (APX) or sham surgery. Meal patterns were analysed under ad libitum and post-deprivation conditions. The importance of the AP in mediating the anorectic action of sCT was examined in feeding experiments of dose-response effects of sCT in APX vs. sham rats. The effect of sCT to induce Fos expression was compared between surgery groups, and relative to amylin. The phenotype of Fos-expressing neurons in the brainstem was examined by testing for the co-expression of dopamine beta hydroxylase (DBH) or tryptophan hydroxylase (TPH). By measuring the apposition of vesicular glutamate transporter-2 (VGLUT2)-positive boutons, potential glutamatergic input to amylin- and sCT-activated AP neurons was compared. Similar to amylin, an intact AP was necessary for sCT to reduce eating. Further, co-expression between Fos activation and DBH after amylin or sCT did not differ markedly, while co-localization of Fos and TPH was minor. Approximately 95% of neurons expressing Fos and DBH after amylin or sCT treatment were closely apposed to VGLUT2-positive boutons. Our study suggests that the hindbrain pathways engaged by amylin and sCT share many similarities, including the mediation by AP neurons.
© 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  AP lesion; VGLUT2; meal pattern analysis; noradrenaline; rat

Mesh:

Substances:

Year:  2014        PMID: 25040689     DOI: 10.1111/ejn.12672

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

1.  The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc).

Authors:  Lynda Whiting; James E McCutcheon; Christina N Boyle; Mitchell F Roitman; Thomas A Lutz
Journal:  Physiol Behav       Date:  2017-03-22

Review 2.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

3.  Amylin Selectively Signals Onto POMC Neurons in the Arcuate Nucleus of the Hypothalamus.

Authors:  Thomas A Lutz; Bernd Coester; Lynda Whiting; Ambrose A Dunn-Meynell; Christina N Boyle; Sebastien G Bouret; Barry E Levin; Christelle Le Foll
Journal:  Diabetes       Date:  2018-02-21       Impact factor: 9.461

4.  A genetic map of the mouse dorsal vagal complex and its role in obesity.

Authors:  Mette Q Ludwig; Wenwen Cheng; Desiree Gordian; Julie Lee; Sarah J Paulsen; Stine N Hansen; Kristoffer L Egerod; Pernille Barkholt; Christopher J Rhodes; Anna Secher; Lotte Bjerre Knudsen; Charles Pyke; Martin G Myers; Tune H Pers
Journal:  Nat Metab       Date:  2021-03-25

Review 5.  Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.

Authors:  T A Lutz
Journal:  Int J Obes Suppl       Date:  2016-11-16

Review 6.  Mediators of Amylin Action in Metabolic Control.

Authors:  Christina N Boyle; Yi Zheng; Thomas A Lutz
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

7.  GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.

Authors:  Samantha M Fortin; Rachele K Lipsky; Rinzin Lhamo; Jack Chen; Eun Kim; Tito Borner; Heath D Schmidt; Matthew R Hayes
Journal:  Sci Transl Med       Date:  2020-03-04       Impact factor: 17.956

8.  The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats.

Authors:  Lauren M Stein; Lauren E McGrath; Rinzin Lhamo; Kieran Koch-Laskowski; Samantha M Fortin; Jolanta Skarbaliene; Tamara Baader-Pagler; Rasmus Just; Matthew R Hayes; Elizabeth G Mietlicki-Baase
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-07-14       Impact factor: 3.210

9.  Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling.

Authors:  Christelle Le Foll; Miranda D Johnson; Ambrose A Dunn-Meynell; Christina N Boyle; Thomas A Lutz; Barry E Levin
Journal:  Diabetes       Date:  2014-11-19       Impact factor: 9.461

Review 10.  Amylin at the interface between metabolic and neurodegenerative disorders.

Authors:  Thomas A Lutz; Urs Meyer
Journal:  Front Neurosci       Date:  2015-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.